(19)
(11)
EP 1 194 544 A1
(12)
(43)
Date of publication:
10.04.2002
Bulletin 2002/15
(21)
Application number:
00941478.0
(22)
Date of filing:
16.06.2000
(51)
International Patent Classification (IPC)
7
:
C12N
15/12
,
C12N
15/63
,
C12N
15/62
,
C12N
15/67
,
C12N
15/86
,
C07K
14/47
,
A01K
67/027
,
A61K
48/00
(86)
International application number:
PCT/US0016/620
(87)
International publication number:
WO 0078/951
(
28.12.2000
Gazette 2000/52)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
18.06.1999
US 140289 P
(71)
Applicant:
ARIAD GENE THERAPEUTICS, INC.
Cambridge, MA 02139-4234 (US)
(72)
Inventor:
NATESAN, Sridaran
Chestnut Hill, MA 02167 (US)
(74)
Representative:
VOSSIUS & PARTNER
Siebertstrasse 4
81675 München
81675 München (DE)
(54)
CHIMERIC OCA-B TRANSCRIPTION FACTORS